Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ISCHEMIC STROKE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
graph TD
ISCHEMIC_STROKE["ISCHEMIC STROKE"]
style ISCHEMIC_STROKE fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
ISCHEMIC_STROKE -->|"causes"| Neuroinflammation["Neuroinflammation"]
ISCHEMIC_STROKE -->|"causes"| Blood_Brain_Barrier_Disruption["Blood-Brain Barrier Disruption"]
ISCHEMIC_STROKE -->|"upregulates"| IFI27L2A([IFI27L2A])
ISCHEMIC_STROKE -->|"causes"| blood_brain_barrier_integrity["blood-brain barrier integrity"]
ISCHEMIC_STROKE -->|"causes"| neuronal_cell_death["neuronal cell death"]
ISCHEMIC_STROKE -->|"causes"| neuroinflammation["neuroinflammation"]
Gnetupendin_A["Gnetupendin A"] -.->|"protects against"| ISCHEMIC_STROKE
PI3K_AKT["PI3K/AKT"] -->|"regulates"| ISCHEMIC_STROKE
Triolein["Triolein"] -->|"treats"| ISCHEMIC_STROKE
Tissue_Plasminogen_Activator{"Tissue Plasminogen Activator"} -->|"treats"| ISCHEMIC_STROKE
Lipid_nanoparticles{"Lipid nanoparticles"} -->|"treats"| ISCHEMIC_STROKE
Rehmannioside_A["Rehmannioside A"] -.->|"protects against"| ISCHEMIC_STROKE
Excitotoxicity["Excitotoxicity"] -->|"contributes to"| ISCHEMIC_STROKE
Remote_Ischemic_Conditioning["Remote Ischemic Conditioning"] -.->|"protects against"| ISCHEMIC_STROKE
KLF11["KLF11"] -.->|"protects against"| ISCHEMIC_STROKE
B_glomerulata{"B.glomerulata"} -->|"treats"| ISCHEMIC_STROKE| Target | Relation | Type | Str |
|---|---|---|---|
| Cerebral Edema | causes | disease | 0.95 |
| Blood-Brain Barrier Disruption | causes | process | 0.95 |
| Neuroinflammation | causes | process | 0.95 |
| IFI27L2A | upregulates | gene | 0.90 |
| Microglia | activates | cell_type | 0.90 |
| neuroinflammatory cascade | associated_with | process | 0.90 |
| Amyloid-beta | promotes | compound | 0.85 |
| blood-brain barrier integrity | causes | process | 0.70 |
| neuronal cell death | causes | process | 0.70 |
| Reactive oxygen species | associated_with | process | 0.70 |
| neuroinflammation | causes | process | 0.70 |
| ENDOTHELIAL CELLS | inhibits | concept | 0.50 |
| CENTRAL NERVOUS SYSTEM | associated_with | concept | 0.50 |
| ENDOTHELIAL CELLS | associated_with | concept | 0.50 |
| CENTRAL NERVOUS SYSTEM | causes | concept | 0.50 |
| NUCLEUS | associated_with | concept | 0.50 |
| ENDOTHELIAL CELLS | regulates | concept | 0.50 |
| STEM CELLS | regulates | concept | 0.50 |
| EXTRACELLULAR VESICLES | regulates | concept | 0.50 |
| MTOR SIGNALING | regulates | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PI3K/AKT | regulates | pathway | 0.95 |
| GW201 | protects_against | compound | 0.95 |
| 116B | treats | compound | 0.95 |
| Gnetupendin A | protects_against | compound | 0.95 |
| PLAT | treats | protein | 0.95 |
| Vagus Nerve Stimulation | protects_against | process | 0.95 |
| Triolein | treats | compound | 0.95 |
| Astrocytic Glycophagy | contributes_to | process | 0.93 |
| Neuroinflammation | contributes_to | process | 0.92 |
| Zinc Finger Proteins | therapeutic_target | protein | 0.90 |
| Tissue Plasminogen Activator | treats | drug | 0.90 |
| Lipid nanoparticles | treats | drug | 0.90 |
| CLEC7A | associated_with | gene | 0.90 |
| Excitotoxicity | contributes_to | process | 0.90 |
| KLF11 | protects_against | entity | 0.90 |
| B.glomerulata | treats | drug | 0.90 |
| CMPK2 | contributes_to | gene | 0.90 |
| Remote Ischemic Conditioning | protects_against | process | 0.90 |
| neuroexcitotoxicity | contributes_to | process | 0.90 |
| TAZ | protects_against | gene | 0.90 |
| Nmda Receptor | contributes_to | receptor | 0.90 |
| C1Q | associated_with | entity | 0.90 |
| oxidative stress | contributes_to | phenotype | 0.90 |
| cerebral edema | associated_with | disease | 0.90 |
| Rehmannioside A | protects_against | compound | 0.90 |
| Asparagine Endopeptidase | protects_against | protein | 0.90 |
| Glymphatic Dysfunction | contributes_to | mechanism | 0.90 |
| Ruxolitinib | protects_against | drug | 0.90 |
| Middle Cerebral Artery Occlusion/Reperfusion | associated_with | process | 0.85 |
| cGAMP | treats | compound | 0.85 |
| Β-Hydroxybutyrate | treats | compound | 0.85 |
| Cgamp | treats | compound | 0.85 |
| Ceramide | associated_with | compound | 0.85 |
| C1Q | associated_with | gene | 0.85 |
| Ion Channel Dysfunction | associated_with | mechanism | 0.85 |
| Oxidative Stress | contributes_to | process | 0.85 |
| MicroRNAs | biomarker_for | biomarker | 0.85 |
| Long Non-Coding RNAs | biomarker_for | biomarker | 0.85 |
| Ion Channel Dysfunction | contributes_to | mechanism | 0.85 |
| GW201 | treats | compound | 0.85 |
| Neuroinflammation | associated_with | process | 0.85 |
| LGALS9 | biomarker_for | protein | 0.85 |
| Inflammation | causes | process | 0.85 |
| Inflammatory Response | contributes_to | process | 0.85 |
| TFEB | associated_with | gene | 0.85 |
| Litebamine | treats | compound | 0.85 |
| BHB | treats | compound | 0.85 |
| Colonoscopy | causes | process | 0.85 |
| Dysregulated ZFPs | drives | protein | 0.85 |
| Mrna Nanoparticles | treats | drug | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity